Finance

Lists
DSKYF:OTCMKTS
Daiichi Sankyo Co Ltd
US$15,95
-1,24%
(-0,20) 1D
9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DSKYF...
Open
US$16,88
High
US$16,88
Low
US$15,95
Mkt. cap
30,95 ຕື້
Avg. vol.
2,62 ພັນ
Volume
0,00
52-wk high
US$29,10
52-wk low
US$13,85
Beta
-1,13
Shares outstanding
1,86 ຕື້
No. of employees
20 ພັນ
Open
US$16,88
High
US$16,88
Low
US$15,95
Mkt. cap
30,95 ຕື້
Avg. vol.
2,62 ພັນ
Volume
0,00
52-wk high
US$29,10
52-wk low
US$13,85
Beta
-1,13
Shares outstanding
1,86 ຕື້
No. of employees
20 ພັນ
News stories
From web sources and news partners
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey. Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries. Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees20,2 ພັນ
Founded28 ກ.ຍ. 2005
HeadquartersChuo City, ໂຕກຽວ, ຍີ່ປຸ່ນ
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
500,76 ຕື້
558,11 ຕື້
589,59 ຕື້
574,74 ຕື້
Cost of goods sold
155,98 ຕື້
118,28 ຕື້
302,44 ຕື້
124,29 ຕື້
Cost of revenue
155,98 ຕື້
118,28 ຕື້
302,44 ຕື້
124,29 ຕື້
Research and development expenses
111,72 ຕື້
122,11 ຕື້
126,23 ຕື້
115,46 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
189,08 ຕື້
228,23 ຕື້
154,06 ຕື້
249,96 ຕື້
Operating expense
297,25 ຕື້
350,29 ຕື້
279,38 ຕື້
365,35 ຕື້
Total operating expenses
453,23 ຕື້
468,57 ຕື້
581,82 ຕື້
489,64 ຕື້
Operating income
47,52 ຕື້
89,54 ຕື້
7,77 ຕື້
85,10 ຕື້
Other non operating income
-
-
6,22 ຕື້
-2,00 ລ້ານ
EBT including unusual items
57,78 ຕື້
106,73 ຕື້
22,44 ຕື້
91,34 ຕື້
EBT excluding unusual items
57,78 ຕື້
106,73 ຕື້
7,84 ຕື້
91,34 ຕື້
Income tax expense
12,46 ຕື້
20,10 ຕື້
-39,84 ຕື້
22,70 ຕື້
Effective tax rate
21,57%
18,83%
-177,52%
24,86%
Other operating expenses
-3,56 ຕື້
-49,00 ລ້ານ
-908,00 ລ້ານ
-69,00 ລ້ານ
Net income
45,31 ຕື້
86,63 ຕື້
62,28 ຕື້
68,64 ຕື້
Net profit margin
9,05%
15,52%
10,56%
11,94%
Earnings per share
-
-
-
-
Interest and investment income
10,68 ຕື້
19,08 ຕື້
377,00 ລ້ານ
9,74 ຕື້
Interest expense
-834,00 ລ້ານ
-2,16 ຕື້
-18,91 ຕື້
-3,23 ຕື້
Net interest expenses
9,84 ຕື້
16,91 ຕື້
-18,53 ຕື້
6,51 ຕື້
Depreciation and amortization charges
-
-
-
-
EBITDA
66,41 ຕື້
109,18 ຕື້
28,89 ຕື້
106,58 ຕື້
Gain or loss from assets sale
1,75 ຕື້
573,00 ລ້ານ
8,50 ຕື້
180,00 ລ້ານ
AI content may include mistakes. Learn more
ແອັບຂອງ Google